cyc 202 has been researched along with Uveitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duan, J; Hall, M; Leskov, KS; Liu, Q; Rosenbaum, JT; Wu, X; Zhang, GL; Zhang, Z | 1 |
Jiang, ZX; Lin, XF; Lou, BS; Qiu, S; Wang, WC; Yang, Y | 1 |
2 other study(ies) available for cyc 202 and Uveitis
Article | Year |
---|---|
Roscovitine suppresses CD4+ T cells and T cell-mediated experimental uveitis.
Topics: Animals; Antibodies; Autoimmune Diseases; CD28 Antigens; CD3 Complex; CD4-Positive T-Lymphocytes; Cell Proliferation; Cyclin-Dependent Kinase 2; G1 Phase; Gene Expression; Hyaluronan Receptors; Immunologic Factors; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Ovalbumin; Protein Kinase Inhibitors; Purines; Receptors, OX40; Roscovitine; S Phase; Uveitis | 2013 |
Roscovitine ameliorates endotoxin-induced uveitis through neutrophil apoptosis.
Topics: Animals; Apoptosis; Caspase 3; Cytokines; Disease Models, Animal; Endotoxins; Female; Inflammation Mediators; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Neutrophil Infiltration; Neutrophils; Protein Kinase Inhibitors; Purines; Roscovitine; Uveitis | 2016 |